EUR J GASTROEN HEPAT 润色咨询

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

出版年份:1989 年文章数:3733 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2021-03-03 萧念

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:胃肠方向;肝病方向
    经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。

    8

    展开8条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2022-08-04 ms5000001116886064

    偏重的研究方向:肝病方向
    经验分享:请问这个杂志修回会被拒稿吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2020-05-15 xxk7235

    这个投稿后如果没有所有作者都确认,是不是就无法送审?

    5

    展开5条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2022-03-05 ms4000001510803725

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:小肠
    经验分享:个案很快被拒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2022-02-16 ms2000000713462597

    方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2021-12-29 Gym璨烨

    如果文章发表了未提供ORCIDID如何添加?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    什么是SCI?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2021-01-28 日月花

    分享一下投稿链接,谢谢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2015-07-25 seeyoutomorrow

    请问一下,这个杂志的要不要稿费啊,彩图多少钱?

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=945101, encodeId=6602945101ae, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:胃肠方向;肝病方向<br>经验分享:这个杂志感觉投稿相对容易,比较容易中,可能是需要idea有些创新就可以了,审稿周期很快,基本一般是一个月左右,但是貌似接受后见刊时间比较长,因此,需要等着用文章的同学还是要考虑一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKYl6nqJRiaUqRK63icztC1XXia2L0dnvuBdI5oqmfFM7pOMNCXtI7r9ONuYFVJL2cuXFPX9ia3lAAtFw/132, createdBy=7b5d5242792, createdName=萧念, createdTime=Wed Mar 03 13:02:06 CST 2021, time=2021-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236485, encodeId=c3a6123648576, content=偏重的研究方向:肝病方向<br>经验分享:请问这个杂志修回会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb305679338, createdName=ms5000001116886064, createdTime=Thu Aug 04 02:02:05 CST 2022, time=2022-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590893, encodeId=be3659089335, content=这个投稿后如果没有所有作者都确认,是不是就无法送审?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/19/6ece44052399ee393db05a36ccd32433.jpg, createdBy=29927412, createdName=xxk7235, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199693, encodeId=bf111199693f5, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:小肠<br>经验分享:个案很快被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5186144230, createdName=ms4000001510803725, createdTime=Sat Mar 05 17:10:44 CST 2022, time=2022-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194007, encodeId=18a2119400ee3, content=方向:临床胶囊内镜数据文章 可能是创新不强吧,3天就被拒了,无理由。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Wed Feb 16 12:57:31 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090255, encodeId=fc641090255a3, content=如果文章发表了未提供ORCIDID如何添加?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090256, encodeId=69fb1090256c8, content=什么是SCI?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920740, encodeId=293c920e40e1, content=分享一下投稿链接,谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7c351657961, createdName=日月花, createdTime=Thu Jan 28 14:04:14 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513887, encodeId=f73051388ec3, content=请问一下,这个杂志的要不要稿费啊,彩图多少钱?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=610, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ca1634998, createdName=seeyoutomorrow, createdTime=Sat Jul 25 15:56:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800043, encodeId=e6e980004386, content=官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21ac5395629, createdName=ms2000001231784364, createdTime=Sat Jun 27 21:00:49 CST 2020, time=2020-06-27, status=1, ipAttribution=)]
    2020-06-27 ms2000001231784364

    官网上找不到文章投稿格式,前辈能发一下嘛?第一次投,谢谢谢谢

    0

共109条页码: 2/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分